First Washington Corp’s Precigen PGEN Stock Holding History

First Washington Corp’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-646,575	Closed	-$918K	–	59
2023 Q3	$918K	Buy	646,575 +53,600	+9%	+$76K	0.37%	52
2023 Q2	$682K	Hold	592,975	–	–	0.3%	50
2023 Q1	$629K	Hold	592,975	–	–	0.31%	52
2022 Q4	$901K	Buy	592,975 +6,574	+1%	+$11.3K	0.44%	51
2022 Q3	$1.24M	Hold	586,401	–	–	0.63%	54
2022 Q2	$786K	Sell	586,401 -1,563	-0.3%	-$2.32K	0.36%	54
2022 Q1	$1.24M	Buy	587,964 +14,660	+3%	+$35.7K	0.5%	52
2021 Q4	$2.13M	Sell	573,304 -3,666	-0.6%	-$15.8K	0.82%	43
2021 Q3	$2.88M	Hold	576,970	–	–	1.05%	48
2021 Q2	$3.76M	Hold	576,970	–	–	1.4%	38
2021 Q1	$3.98M	Buy	576,970 +100,000	+21%	+$845K	1.57%	26
2020 Q4	$4.87M	Sell	476,970 -7,570	-2%	-$49.1K	2.2%	13
2020 Q3	$1.7M	Hold	484,540	–	–	1.02%	36
2020 Q2	$2.42M	Sell	484,540 -113,200	-19%	-$385K	1.42%	27
2020 Q1	$2.03M	Sell	597,740 -283,490	-32%	-$1.22M	1.28%	31
2019 Q4	$4.83M	Sell	881,230 -20,353	-2%	-$115K	2.22%	22
2019 Q3	$5.16M	Hold	901,583	–	–	2.56%	15
2019 Q2	$6.91M	Buy	901,583 +352,720	+64%	+$1.9M	3.4%	7
2019 Q1	$2.89M	Buy	548,863 +274,340	+100%	+$1.9M	1.46%	33
2018 Q4	$1.79M	Sell	274,523 -4,580	-2%	-$51.3K	0.98%	40
2018 Q3	$4.81M	Buy	279,103 +173	+0.1%	+$2.57K	2.28%	17
2018 Q2	$3.89M	Hold	278,930	–	–	1.93%	22
2018 Q1	$4.28M	Sell	278,930 -11,060	-4%	-$158K	2.22%	18
2017 Q4	$3.34M	Buy	289,990 +93,280	+47%	+$1.39M	1.57%	29
2017 Q3	$3.74M	Buy	196,710 +42,180	+27%	+$868K	1.86%	23
2017 Q2	$37.2K	Hold	154,530	–	–	1.86%	24
2017 Q1	$3.06M	Buy	154,530 +36,255	+31%	+$809K	1.68%	28
2016 Q4	$2.85M	Buy	118,275 +686	+0.6%	+$19.1K	1.56%	29
2016 Q3	$3.27M	Hold	117,589	–	–	1.83%	20
2016 Q2	$2.87M	Buy	117,589 +21,018	+22%	+$596K	1.65%	28
2016 Q1	$3.24M	Hold	96,571	–	–	1.92%	22
2015 Q4	$2.89M	Sell	96,571 -404	-0.4%	-$13.6K	1.68%	32
2015 Q3	$3.06M	Buy	96,975 +20,594	+27%	+$1M	1.84%	20
2015 Q2	$3.69M	Sell	76,381 -2,826	-4%	-$119K	2.06%	20
2015 Q1	$3.44M	Sell	79,207 -48,027	-38%	-$1.73M	1.99%	21
2014 Q4	$3.35M	Buy	127,234 +732	+0.6%	+$16.1K	1.98%	23
2014 Q3	$2.25M	Buy	126,502 +125,979	+24,088%	+$2.57M	1.28%	38
2014 Q2	$13K	Hold	523	–	–	0.01%	112
2014 Q1	$13K	Buy	+523	New	+$14.5K	0.01%	111

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Washington Corp's PGEN Position: Q4 2023 in Review

First Washington Corp sold out of Precigen (PGEN) in Q4 2023, closing a stake of 646,575 shares — an estimated $918K sold.

First Washington Corp first reported a position in PGEN in Q1 2014 and held it in 39 quarters. The position peaked at $6.91M in Q2 2019. 137 funds tracked by Wall St. Rank hold PGEN as of Q4 2023.

First Washington Corp reported no remaining Precigen position as of Q4 2023 after selling out during the quarter.
First Washington Corp sold 646,575 Precigen shares in Q4 2023, an estimated $918K.
First Washington Corp first reported a position in Precigen in Q1 2014 and held it in 39 quarters.
First Washington Corp's Precigen position peaked at $6.91M in Q2 2019.
137 funds tracked by Wall St. Rank held Precigen as of Q4 2023.

Based on First Washington Corp's 13F filing for Q4 2023, filed 14 Feb 2024.